acf/google-ad-placement

<ul>
	<li>Pfizer Inc&nbsp;PFE and&nbsp;BioNTech SE&nbsp;BNTX have&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/21/09/b23007527/pfizer-and-biontech-announce-positive-topline-results-from-pivotal-trial-of-covid-19-vaccine-in-ch" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">announced results from one cohort</a>&nbsp;from a Phase 2/3 trial evaluating its COVID-19 vaccine on a two-dose schedule (approximately 21 days apart).</li>
	<li>The data from over 2,200 children aged 5 to 11 years showed a favorable safety profile and robust neutralizing antibody responses using a two-dose regimen of 10 &micro;g, a smaller dose than the 30 &micro;g dose used for people 12 and older.&nbsp;</li>
	<li>The antibody responses in the participants given 10 &micro;g doses were comparable to those in a prior study in people 16 to 25 immunized with 30 &micro;g doses.&nbsp;</li>
	<li>Further, the COVID-19 vaccine was well tolerated, with side effects generally comparable to those observed in participants 16 to 25 years of age.</li>
	<li>The companies plan to submit the data to the FDA and other health regulators &quot;as soon as possible.&quot;</li>
	<li>Topline readouts for the other two age cohorts from the trial &ndash; children 2-5 years of age and 6 months to 2 years are expected in Q4 of 2021.</li>
	<li>Read Next:&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/general/biotech/21/09/22997460/fda-panel-votes-against-approval-of-pfizerbiontechs-covid-19-booster-shot-for-general-public" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">FDA Panel Votes Against Approval Of Pfizer/BioNTech&#39;s COVID-19 Booster Shot For General Public</a>.</li>
	<li>Price Action:&nbsp;PFE stock is down 1.53% at $43.22, while BNTX stock is down 5.27% at $340.24 during the premarket session on the last check Monday.</li>
	<li>Photo by x3 from Pixabay</li>
</ul>

Biotech

News

Application error: a client-side exception has occurred (see the browser console for more information).